118 related articles for article (PubMed ID: 7636854)
1. Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors.
Quan ML; Chiu AT; Ellis CD; Wong PC; Wexler RR; Timmermans PB
J Med Chem; 1995 Jul; 38(15):2938-45. PubMed ID: 7636854
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
Wong PC; Quan ML; Saye JM; Bernard R; Crain EJ; McCall DE; Watson CA; Zaspel AM; Smith RD; Wexler RR
J Cardiovasc Pharmacol; 1995 Sep; 26(3):354-62. PubMed ID: 8583775
[TBL] [Abstract][Full Text] [Related]
3. Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.
Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Kivlighn SD; Siegl PK; Lotti VJ; Chang RS
J Med Chem; 1995 Sep; 38(19):3741-58. PubMed ID: 7562905
[TBL] [Abstract][Full Text] [Related]
4. EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes.
Wong PC; Duncia JV; Santella JB; Smith RD; Wexler RR; Timmermans PB; Chiu AT
Eur J Pharmacol; 1994 Aug; 260(2-3):261-4. PubMed ID: 7988654
[TBL] [Abstract][Full Text] [Related]
5. Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.
Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
J Med Chem; 1993 Dec; 36(26):4239-49. PubMed ID: 8277506
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ
Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Chang RS; Ondeyka DL; Mantlo NB; Gibson RE; Greenlee WJ; Siegl PK
Eur J Pharmacol; 1995 Dec; 294(2-3):439-50. PubMed ID: 8750704
[TBL] [Abstract][Full Text] [Related]
9. Selective changes in angiotensin II AT1 and AT2 receptor subtypes in the rat superior colliculus following eye enucleation.
Michels KM; Heemskerk FM; Saavedra JM
Neuroscience; 1994 Feb; 58(4):835-44. PubMed ID: 8190260
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
[TBL] [Abstract][Full Text] [Related]
11. Identification of atypical (non-AT1, non-AT2) angiotensin binding sites with high affinity for angiotensin I on IEC-18 rat intestinal epithelial cells.
Smith RD
FEBS Lett; 1995 Oct; 373(3):199-202. PubMed ID: 7589465
[TBL] [Abstract][Full Text] [Related]
12. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436.
Delisée C; Schaeffer P; Cazaubon C; Chatelain P
Eur J Pharmacol; 1993 Oct; 247(2):139-44. PubMed ID: 8282003
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
[TBL] [Abstract][Full Text] [Related]
15. Development of [11C]L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging.
Hamill TG; Burns HD; Dannals RF; Mathews WB; Musachio JL; Ravert HT; Naylor EM
Appl Radiat Isot; 1996 Feb; 47(2):211-8. PubMed ID: 8852629
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
Clark KL; Robertson MJ; Drew GM
Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
[TBL] [Abstract][Full Text] [Related]
18. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts.
Lopez JJ; Lorell BH; Ingelfinger JR; Weinberg EO; Schunkert H; Diamant D; Tang SS
Am J Physiol; 1994 Aug; 267(2 Pt 2):H844-52. PubMed ID: 8067441
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells.
Balmforth AJ; Bryson SE; Aylett AJ; Warburton P; Ball SG; Pun KT; Middlemiss D; Drew GM
Br J Pharmacol; 1994 May; 112(1):277-81. PubMed ID: 8032651
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension.
Chatziantoniou C; Arendshorst WJ
Am J Physiol; 1993 Dec; 265(6 Pt 2):F853-62. PubMed ID: 8285218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
